Literature DB >> 25296277

The direction of the difference between Canadian and American erythrocyte folate concentrations is dependent on the assay method employed: a comparison of the Canadian Health Measures Survey and National Health and Nutrition Examination Survey.

Cynthia K Colapinto1, Mark S Tremblay1, Susanne Aufreiter2, Tracey Bushnik3, Christine M Pfeiffer4, Deborah L O'Connor2.   

Abstract

Fortification of select grain products with folic acid and periconceptional supplementation recommendations in Canada and the USA have improved folate status, and have been associated with a reduced risk of neural tube defects. In the present study, we aimed to conduct a comparison of erythrocyte folate concentrations from the 2007-9 Canadian Health Measures Survey (CHMS) and the 2007-8 US National Health and Nutrition Examination Survey (NHANES). Erythrocyte folate concentration was assessed in participants aged 6-79 years (CHMS, n 5248; NHANES, n 7070). To account for different folate assays employed - Immulite 2000 immunoassay (CHMS) and microbiological assay (NHANES) - a conversion equation was generated (n 152 adults) to adjust the CHMS data. t Tests were used to examine country differences. Median Canadian erythrocyte folate concentrations (method-adjusted) were lower than those of Americans (988 and 1100 nmol/l, respectively), but unadjusted median Canadian erythrocyte folate concentrations were higher (1250 nmol/l). The upper 95% CI boundary of the method-adjusted Canadian erythrocyte folate distribution overlapped that of the American erythrocyte folate concentrations, while the lower 95% CI boundary of the method-adjusted Canadian erythrocyte folate data was below the American distribution. In summary, the fact that erythrocyte folate concentrations were either higher or lower in Canadians compared with Americans, depending on whether an adjustment was made to account for assay differences, suggests that caution must be exercised in evaluating erythrocyte folate data from different countries because analytical methods are not readily comparable. Furthermore, we cannot unequivocally conclude that there are true differences in erythrocyte folate concentrations between the Canadian and American populations in the post-fortification era.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25296277      PMCID: PMC4806528          DOI: 10.1017/S0007114514002906

Source DB:  PubMed          Journal:  Br J Nutr        ISSN: 0007-1145            Impact factor:   3.718


  28 in total

1.  Canadian Health Measures Survey: ethical, legal and social issues.

Authors:  Brent Day; Renée Langlois; Mark Tremblay; Bartha-Maria Knoppers
Journal:  Health Rep       Date:  2007       Impact factor: 4.796

2.  Results of an international round robin for serum and whole-blood folate.

Authors:  E W Gunter; B A Bowman; S P Caudill; D B Twite; M J Adams; E J Sampson
Journal:  Clin Chem       Date:  1996-10       Impact factor: 8.327

Review 3.  Variance estimation for complex surveys using replication techniques.

Authors:  K F Rust; J N Rao
Journal:  Stat Methods Med Res       Date:  1996-09       Impact factor: 3.021

4.  Decline in the prevalence of spina bifida and anencephaly by race/ethnicity: 1995-2002.

Authors:  Laura J Williams; Sonja A Rasmussen; Alina Flores; Russell S Kirby; Larry D Edmonds
Journal:  Pediatrics       Date:  2005-09       Impact factor: 7.124

5.  The effect of folate fortification of cereal-grain products on blood folate status, dietary folate intake, and dietary folate sources among adult non-supplement users in the United States.

Authors:  Marion Dietrich; Coralie J P Brown; Gladys Block
Journal:  J Am Coll Nutr       Date:  2005-08       Impact factor: 3.169

6.  Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. MRC Vitamin Study Research Group.

Authors: 
Journal:  Lancet       Date:  1991-07-20       Impact factor: 79.321

7.  Evaluation of regression procedures for methods comparison studies.

Authors:  K Linnet
Journal:  Clin Chem       Date:  1993-03       Impact factor: 8.327

8.  Influence of 5,10-methylenetetrahydrofolate reductase polymorphism on whole-blood folate concentrations measured by LC-MS/MS, microbiologic assay, and bio-rad radioassay.

Authors:  Zia Fazili; Christine M Pfeiffer; Mindy Zhang; Ram B Jain; Deborah Koontz
Journal:  Clin Chem       Date:  2008-01       Impact factor: 8.327

9.  Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation.

Authors:  A E Czeizel; I Dudás
Journal:  N Engl J Med       Date:  1992-12-24       Impact factor: 91.245

10.  Reduction in neural-tube defects after folic acid fortification in Canada.

Authors:  Philippe De Wals; Fassiatou Tairou; Margot I Van Allen; Soo-Hong Uh; R Brian Lowry; Barbara Sibbald; Jane A Evans; Michiel C Van den Hof; Pamela Zimmer; Marian Crowley; Bridget Fernandez; Nora S Lee; Theophile Niyonsenga
Journal:  N Engl J Med       Date:  2007-07-12       Impact factor: 91.245

View more
  7 in total

1.  Folate and neural tube defects: The role of supplements and food fortification.

Authors:  Noam Ami; Mark Bernstein; François Boucher; Michael Rieder; Louise Parker
Journal:  Paediatr Child Health       Date:  2016-04       Impact factor: 2.253

Review 2.  Challenges and Lessons Learned in Generating and Interpreting NHANES Nutritional Biomarker Data.

Authors:  Christine M Pfeiffer; David A Lacher; Rosemary L Schleicher; Clifford L Johnson; Elizabeth A Yetley
Journal:  Adv Nutr       Date:  2017-03-15       Impact factor: 8.701

3.  The effectiveness of daily supplementation with 400 or 800 µg/day folate in reaching protective red blood folate concentrations in non-pregnant women: a randomized trial.

Authors:  Rima Obeid; Christiane Schön; Manfred Wilhelm; Klaus Pietrzik; Stefan Pilz
Journal:  Eur J Nutr       Date:  2017-04-26       Impact factor: 5.614

4.  Red Blood Cell Folate Likely Overestimated in Australian National Survey: Implications for Neural Tube Defect Risk.

Authors:  Shannon E Hunt; Merryn J Netting; Thomas R Sullivan; Karen P Best; Lisa A Houghton; Maria Makrides; Beverly S Muhlhausler; Tim J Green
Journal:  Nutrients       Date:  2020-05-01       Impact factor: 5.717

5.  Weekly iron-folic acid supplements containing 2.8 mg folic acid are associated with a lower risk of neural tube defects than the current practice of 0.4 mg: a randomised controlled trial in Malaysia.

Authors:  Kaitlyn L I Samson; Su Peng Loh; Siew Siew Lee; Dian C Sulistyoningrum; Geok Lin Khor; Zalilah Binti Mohd Shariff; Irmi Zarina Ismai; Lisa N Yelland; Shalem Leemaqz; Maria Makrides; Jennifer A Hutcheon; Marion L Roche; Crystal D Karakochuk; Timothy J Green
Journal:  BMJ Glob Health       Date:  2020-12

Review 6.  Maternal folic acid and multivitamin supplementation: International clinical evidence with considerations for the prevention of folate-sensitive birth defects.

Authors:  R D Wilson; D L O'Connor
Journal:  Prev Med Rep       Date:  2021-10-25

7.  Folate-Dependent Hydrolysis of Acetyl-Coenzyme A by Recombinant Human and Rodent Arylamine N-Acetyltransferases.

Authors:  Marcus W Stepp; Galina Mamaliga; Mark A Doll; J Christopher States; David W Hein
Journal:  Biochem Biophys Rep       Date:  2015-09
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.